In a six-month study, the Tecnis Synergy IOL provided extensive range of vision and spectacle independence in the vast majority of patients with presbyopia.
Discover the only FDA-approved treatment for this rare disease.
See how TEPEZZA can help.
TEPEZZA is a trademark owned by or licensed to Horizon.© 2021 Horizon Therapeutics plc P-TEP-01314 08/21
Public & Patients
Museum of the Eye